General data DKGAAP

Group
Period 1
Report typeInterim report (other than 6 months)
Type of auditor assistanceNo audit assistance
Tool for preparing the XBRL-instance documentParsePort XBRL Converter
Start date of reporting period 12023-01-01
End date of reporting period 12023-03-31
Start date of reporting period 22022-01-01
End date of reporting period 22022-03-31
Name of reporting entityNovo Nordisk A/S
Class of reporting entityReporting class D
Identification number [CVR] of reporting entity24256790
Address of reporting entity, street nameNovo Allé
Address of reporting entity, street building identifier1
Address of reporting entity, post code identifier2880
Address of reporting entity, district nameBagsværd
Address of reporting entity, countryDenmark
Telephone number of reporting entity+4544448888
Homepage of reporting entitywww.novonordisk.com
Place of signature of statement by managementBagsværd
Date of approval of annual report2023-05-04
Name and surname of member of executive board 1Lars Fruergaard Jørgensen
Title of member of executive board 1President and CEO
Name and surname of member of executive board 2Karsten Munk Knudsen
Title of member of executive board 2CFO
Name and surname of member of executive board 3Martin Holst Lange
Name and surname of member of executive board 4Marcus Schindler
Name and surname of member of executive board 5Camilla Sylvest
Name and surname of member of executive board 6Henrik Wulff
Name and surname of member of supervisory board 1Helge Lund
Title of member of supervisory board 1Chair
Name and surname of member of supervisory board 2Henrik Poulsen
Title of member of supervisory board 2Vice chair
Name and surname of member of supervisory board 3Elisabeth Dahl Christensen
Name and surname of member of supervisory board 4Laurence Debroux
Name and surname of member of supervisory board 5Andreas Fibig
Name and surname of member of supervisory board 6Sylvie Grégoire
Name and surname of member of supervisory board 7Liselotte Hyveled
Name and surname of member of supervisory board 8Mette Bøjer Jensen
Name and surname of member of supervisory board 9Kasim Kutay
Name and surname of member of supervisory board 10Christina Law
Name and surname of member of supervisory board 11Martin MacKay
Name and surname of member of supervisory board 12Thomas Rantzau
Identification number [CVR] of submitting enterprise24256790
Name of submitting enterpriseNovo Nordisk A/S
Address of submitting enterprise, street and numberNovo Allé 1
Address of submitting enterprise, postcode and town2880 Bagsværd

Income statement by function

Period 1Period 2
Net sales53,36742,031
Cost of goods sold-8,182-6,917
Gross profit45,18535,114
Sales and distribution costs-12,412-10,183
Research and development costs-6,728-5,206
Administrative costs-1,071-970
Other operating income and expenses, net33392
Operating profit25,00719,147
Financial income852210
Financial expenses-1,122-1,438
Profit before income taxes24,73717,919
Income taxes-4,923-3,709
Net profit for the year19,81414,210
Basic earnings per share8.816.24
Diluted earnings per share8.786.22

Comprehensive income before tax

Period 1Period 2
Net profit for the year19,81414,210
Remeasurements of retirement benefit obligations39325
Exchange rate adjustments of investments in subsidiaries(969)1,087
Cash flow hedges, realisation of previously deferred (gains)/losses(1,026)641
Cash flow hedges, deferred gains/(losses) incurred during the period2,238(652)
Other items3(4)
Tax on other comprehensive income, income/(expense)(341)125
Other comprehensive income for the year, net of tax(56)1,522
Total comprehensive income for the year19,75815,732

Operating activities

Period 1Period 2
Net profit for the year19,81414,210
Adjustments for income taxes in the income statement4,9233,709
Depreciation, amortisation and impairment losses1,7191,650
Other non-cash items20,2307,388
Change in working capital(10,216)1,893
Interest received18848
Interest paid(165)(52)
Income taxes paid(6,679)(5,260)
Net cash generated from operating activities29,81423,586

Investing activities

Period 1Period 2
Purchase of intangible assets(108)(260)
Purchase of property, plant and equipment(4,693)(1,520)
Proceeds from other financial assets33-
Purchase of other financial assets(7)(7)
Purchase of marketable securities(2,354)(1,845)
Sale of marketable securities4821,725
Net cash used in investing activities(6,647)(1,907)

Financing activities

Period 1Period 2
Purchase of treasury shares(5,199)(4,477)
Dividends paid(18,337)(15,690)
Proceeds from issue of bonds-11,120
Proceeds from borrowings-30
Repayment of borrowings(478)(12,855)
Withheld dividend tax3,3932,737
Net cash used in financing activities(20,621)(19,135)

Cash flow statement

Period 1Period 2
Net cash generated from activities before exchange gains/(losses)2,5462,544
Cash and cash equivalents at the beginning of the year12,65310,719
Exchange gains/(losses) on cash and cash equivalents(263)(55)
Cash and cash equivalents at the end of the year14,93613,208

Non-current assets

Period 1Period 2
Intangible assets50,48951,416
Property, plant and equipment70,01466,671
Investments in associated companies270327
Deferred income tax assets14,08013,427
Other receivables and prepayments288206
Other financial assets9411,016
Total non-current assets136,082133,063

Current assets

Period 1Period 2
Inventories25,61524,388
Trade receivables50,50250,560
Tax receivables1,133940
Other receivables and prepayments6,2866,005
Marketable securities12,83510,921
Derivative financial instruments2,6362,727
Cash at bank14,93612,653
Total current assets113,943108,194

Assets

Period 1Period 2
Total assets250,025241,257

Equity

Period 1Period 2
Share capital456456
Treasury shares(6)(6)
Retained earnings77,07080,587
Other reserves2,3542,449
Total equity79,87483,486

Non-current liabilities

Period 1Period 2
Borrowings24,26724,318
Deferred income tax liabilities7,8757,061
Retirement benefit obligations682762
Other liabilities322100
Provisions5,0444,590
Total non-current liabilities38,19036,831

Current liabilities

Period 1Period 2
Borrowings1,2511,466
Trade payables10,05015,587
Tax payables6,0627,091
Other liabilities24,36023,606
Derivative financial instruments2,2822,903
Provisions87,95670,287
Total current liabilities131,961120,940

Liabilities

Period 1Period 2
Total liabilities170,151157,771

Equity and liabilities

Period 1Period 2
Total equity and liabilities250,025241,257

Statement of changes in equity

Period 1Period 1Period 1Period 1Period 1
Share capitalTreasury sharesRetained earningsTotal other reservesTotal
Balance at the beginning of the year456(6)80,5872,44983,486
Net profit for the year19,81419,814
Other comprehensive income for the year39(95)(56)
Total comprehensive income for the year19,853(95)19,758
Dividends(18,337)(18,337)
Share-based payments400400
Tax related to restricted stock units(234)(234)
Purchase of treasury shares(5,199)(5,199)
Balance at the end of the year456(6)77,0702,35479,874

Statement of changes in equity

Period 2Period 2Period 2Period 2Period 2
Share capitalTreasury sharesRetained earningsTotal other reservesTotal
Balance at the beginning of the year462(6)72,004(1,714)70,746
Net profit for the year14,21014,210
Other comprehensive income for the year3251,1971,522
Total comprehensive income for the year14,5351,19715,732
Dividends(15,690)(15,690)
Share-based payments246246
Tax related to restricted stock units(7)(7)
Purchase of treasury shares(1)(4,476)(4,477)
Balance at the end of the year462(7)66,612(517)66,550
549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember1549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember2549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember3549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember4549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember5549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember6549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember1549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember2549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember3549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember4549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember5549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember6549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember7549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember8549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember9549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember10549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember11549300DAQ1CVT6CXN3422023-01-012023-03-31cmn:ConsolidatedMember12549300DAQ1CVT6CXN3422023-01-012023-03-31549300DAQ1CVT6CXN3422022-01-012022-03-31549300DAQ1CVT6CXN3422022-12-31549300DAQ1CVT6CXN3422023-03-31549300DAQ1CVT6CXN3422021-12-31549300DAQ1CVT6CXN3422022-03-31549300DAQ1CVT6CXN3422022-12-31ifrs-full:IssuedCapitalMember549300DAQ1CVT6CXN3422023-03-31ifrs-full:IssuedCapitalMember549300DAQ1CVT6CXN3422022-12-31ifrs-full:TreasurySharesMember549300DAQ1CVT6CXN3422023-03-31ifrs-full:TreasurySharesMember549300DAQ1CVT6CXN3422022-12-31ifrs-full:RetainedEarningsMember549300DAQ1CVT6CXN3422023-01-012023-03-31ifrs-full:RetainedEarningsMember549300DAQ1CVT6CXN3422023-03-31ifrs-full:RetainedEarningsMember549300DAQ1CVT6CXN3422022-12-31ifrs-full:OtherReservesMember549300DAQ1CVT6CXN3422023-01-012023-03-31ifrs-full:OtherReservesMember549300DAQ1CVT6CXN3422023-03-31ifrs-full:OtherReservesMember549300DAQ1CVT6CXN3422021-12-31ifrs-full:IssuedCapitalMember549300DAQ1CVT6CXN3422022-03-31ifrs-full:IssuedCapitalMember549300DAQ1CVT6CXN3422021-12-31ifrs-full:TreasurySharesMember549300DAQ1CVT6CXN3422022-01-012022-03-31ifrs-full:TreasurySharesMember549300DAQ1CVT6CXN3422022-03-31ifrs-full:TreasurySharesMember549300DAQ1CVT6CXN3422021-12-31ifrs-full:RetainedEarningsMember549300DAQ1CVT6CXN3422022-01-012022-03-31ifrs-full:RetainedEarningsMember549300DAQ1CVT6CXN3422022-03-31ifrs-full:RetainedEarningsMember549300DAQ1CVT6CXN3422021-12-31ifrs-full:OtherReservesMember549300DAQ1CVT6CXN3422022-01-012022-03-31ifrs-full:OtherReservesMember549300DAQ1CVT6CXN3422022-03-31ifrs-full:OtherReservesMemberiso4217:DKKiso4217:DKKxbrli:shares